Last reviewed · How we verify
NCT04223674: SSAT
Serological Screen and Treat Trial for Plasmodium Vivax
NA trial testing Serological screen and treat in Malaria, Vivax in 1,133 participants. Status unknown.
30 May 2023
Quick facts
| Lead sponsor | Indonesia University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 1,133 |
| Start date | 9 February 2022 |
| Primary completion | 30 May 2023 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Serological screen and treat
Conditions studied
- Malaria, Vivax — all drugs for Malaria, Vivax →
Sponsor
Indonesia University
Who can join
Adults 6 to 15, any sex, with Malaria, Vivax. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a clinical trial to evaluate an experimental serological diagnostic technique intended to identify people at high risk of having dormant malaria parasites in their liver. The study is designed to evaluate the efficacy of serological screening vs. routine care for the prevention of recurrent P. vivax infections. A total of 960 schoolchildren will be randomized into the interventional or control arm.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD Screening.
Kosasih A, James R, Chau NH, Karman MM, et al · · 2023 · cited 5× · PMID 37764985 · DOI 10.3390/pathogens12091176 -
Abstracts of the 9th International Conference on Plasmodium vivax Research (ICPvR) 2025.
· 2025 · PMID 41327309 · DOI 10.1186/s12936-025-05498-0
Verify or expand the search:
- PubMed search for NCT04223674
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Malaria, Vivax
Currently open trials in the same condition.
- NCT06666491 — An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken · Phase 3 · recruiting
- NCT05788094 — ACT vs CQ With Tafenoquine for P. Vivax Mono-infection · Phase 4 · recruiting
Other Indonesia University trials
Trials by the same sponsor.
- NCT07137130 — Secretome TGF Beta 3 · NA · not yet recruiting
- NCT07420335 — Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy · NA · not yet recruiting
- NCT07278284 — The Effectiveness of Press Needle Acupuncture on Preoperative Anxiety in Tympanoplasty and Mastoidectomy · NA · recruiting
- NCT07337187 — Effect of Thread-Embedding Acupuncture at EX-B2 on Pain and Quality of Life in Chronic Low Back Pain · NA · not yet recruiting
- NCT07242001 — Laser Acupuncture for Otitis Media With Effusion in Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04223674 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indonesia University
- Last refreshed: 7 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04223674.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing